299 related articles for article (PubMed ID: 18524990)
1. Endothelial CD47 interaction with SIRPgamma is required for human T-cell transendothelial migration under shear flow conditions in vitro.
Stefanidakis M; Newton G; Lee WY; Parkos CA; Luscinskas FW
Blood; 2008 Aug; 112(4):1280-9. PubMed ID: 18524990
[TBL] [Abstract][Full Text] [Related]
2. SIRPγ-CD47 Interaction Positively Regulates the Activation of Human T Cells in Situation of Chronic Stimulation.
Dehmani S; Nerrière-Daguin V; Néel M; Elain-Duret N; Heslan JM; Belarif L; Mary C; Thepenier V; Biteau K; Poirier N; Blancho G; Haspot F
Front Immunol; 2021; 12():732530. PubMed ID: 34925315
[TBL] [Abstract][Full Text] [Related]
3. Endothelial CD47 promotes vascular endothelial-cadherin tyrosine phosphorylation and participates in T cell recruitment at sites of inflammation in vivo.
Azcutia V; Stefanidakis M; Tsuboi N; Mayadas T; Croce KJ; Fukuda D; Aikawa M; Newton G; Luscinskas FW
J Immunol; 2012 Sep; 189(5):2553-62. PubMed ID: 22815286
[TBL] [Abstract][Full Text] [Related]
4. BYON4228 is a pan-allelic antagonistic SIRPα antibody that potentiates destruction of antibody-opsonized tumor cells and lacks binding to SIRPγ on T cells.
van Helden MJ; Zwarthoff SA; Arends RJ; Reinieren-Beeren IMJ; Paradé MCBC; Driessen-Engels L; de Laat-Arts K; Damming D; Santegoeds-Lenssen EWH; van Kuppeveld DWJ; Lodewijks I; Olsman H; Matlung HL; Franke K; Mattaar-Hepp E; Stokman MEM; de Wit B; Glaudemans DHRF; van Wijk DEJW; Joosten-Stoffels L; Schouten J; Boersema PJ; van der Vleuten M; Sanderink JWH; Kappers WA; van den Dobbelsteen D; Timmers M; Ubink R; Rouwendal GJA; Verheijden G; van der Lee MMC; Dokter WHA; van den Berg TK
J Immunother Cancer; 2023 Apr; 11(4):. PubMed ID: 37068796
[TBL] [Abstract][Full Text] [Related]
5. Signal-regulatory protein alpha-CD47 interactions are required for the transmigration of monocytes across cerebral endothelium.
de Vries HE; Hendriks JJ; Honing H; De Lavalette CR; van der Pol SM; Hooijberg E; Dijkstra CD; van den Berg TK
J Immunol; 2002 Jun; 168(11):5832-9. PubMed ID: 12023387
[TBL] [Abstract][Full Text] [Related]
6. Human lymphocytes interact directly with CD47 through a novel member of the signal regulatory protein (SIRP) family.
Brooke G; Holbrook JD; Brown MH; Barclay AN
J Immunol; 2004 Aug; 173(4):2562-70. PubMed ID: 15294972
[TBL] [Abstract][Full Text] [Related]
7. Functional CD47/signal regulatory protein alpha (SIRP(alpha)) interaction is required for optimal human T- and natural killer- (NK) cell homeostasis in vivo.
Legrand N; Huntington ND; Nagasawa M; Bakker AQ; Schotte R; Strick-Marchand H; de Geus SJ; Pouw SM; Böhne M; Voordouw A; Weijer K; Di Santo JP; Spits H
Proc Natl Acad Sci U S A; 2011 Aug; 108(32):13224-9. PubMed ID: 21788504
[TBL] [Abstract][Full Text] [Related]
8. Signal regulatory protein (SIRPalpha), a cellular ligand for CD47, regulates neutrophil transmigration.
Liu Y; Bühring HJ; Zen K; Burst SL; Schnell FJ; Williams IR; Parkos CA
J Biol Chem; 2002 Mar; 277(12):10028-36. PubMed ID: 11792697
[TBL] [Abstract][Full Text] [Related]
9. CD47 plays a critical role in T-cell recruitment by regulation of LFA-1 and VLA-4 integrin adhesive functions.
Azcutia V; Routledge M; Williams MR; Newton G; Frazier WA; Manica A; Croce KJ; Parkos CA; Schmider AB; Turman MV; Soberman RJ; Luscinskas FW
Mol Biol Cell; 2013 Nov; 24(21):3358-68. PubMed ID: 24006483
[TBL] [Abstract][Full Text] [Related]
10. Novel role of CD47 in rat microvascular endothelium: signaling and regulation of T-cell transendothelial migration.
Martinelli R; Newton G; Carman CV; Greenwood J; Luscinskas FW
Arterioscler Thromb Vasc Biol; 2013 Nov; 33(11):2566-76. PubMed ID: 23990210
[TBL] [Abstract][Full Text] [Related]
11. Crystal structure of signal regulatory protein gamma (SIRPγ) in complex with an antibody Fab fragment.
Nettleship JE; Ren J; Scott DJ; Rahman N; Hatherley D; Zhao Y; Stuart DI; Barclay AN; Owens RJ
BMC Struct Biol; 2013 Jul; 13():13. PubMed ID: 23826770
[TBL] [Abstract][Full Text] [Related]
12. Novel structural determinants on SIRP alpha that mediate binding to CD47.
Lee WY; Weber DA; Laur O; Severson EA; McCall I; Jen RP; Chin AC; Wu T; Gernert KM; Parkos CA
J Immunol; 2007 Dec; 179(11):7741-50. PubMed ID: 18025220
[TBL] [Abstract][Full Text] [Related]
13. TSP1-CD47-SIRPα signaling facilitates the development of endometriosis by mediating the survival of ectopic endometrium.
Liu Y; Li M; Wei C; Tang L; Sheng Y; Liu Y; Li D; Ding D; Qiu J; Zhu X
Am J Reprod Immunol; 2020 Jun; 83(6):e13236. PubMed ID: 32196807
[TBL] [Abstract][Full Text] [Related]
14. Functional characterization of the selective pan-allele anti-SIRPα antibody ADU-1805 that blocks the SIRPα-CD47 innate immune checkpoint.
Voets E; Paradé M; Lutje Hulsik D; Spijkers S; Janssen W; Rens J; Reinieren-Beeren I; van den Tillaart G; van Duijnhoven S; Driessen L; Habraken M; van Zandvoort P; Kreijtz J; Vink P; van Elsas A; van Eenennaam H
J Immunother Cancer; 2019 Dec; 7(1):340. PubMed ID: 31801627
[TBL] [Abstract][Full Text] [Related]
15. Peptide-mediated inhibition of neutrophil transmigration by blocking CD47 interactions with signal regulatory protein alpha.
Liu Y; O'Connor MB; Mandell KJ; Zen K; Ullrich A; Bühring HJ; Parkos CA
J Immunol; 2004 Feb; 172(4):2578-85. PubMed ID: 14764731
[TBL] [Abstract][Full Text] [Related]
16. Functional elements on SIRPalpha IgV domain mediate cell surface binding to CD47.
Liu Y; Tong Q; Zhou Y; Lee HW; Yang JJ; Bühring HJ; Chen YT; Ha B; Chen CX; Yang Y; Zen K
J Mol Biol; 2007 Jan; 365(3):680-93. PubMed ID: 17070842
[TBL] [Abstract][Full Text] [Related]
17. The CD47-SIRPα signaling axis as an innate immune checkpoint in cancer.
Matlung HL; Szilagyi K; Barclay NA; van den Berg TK
Immunol Rev; 2017 Mar; 276(1):145-164. PubMed ID: 28258703
[TBL] [Abstract][Full Text] [Related]
18. Species- and cell type-specific interactions between CD47 and human SIRPalpha.
Subramanian S; Parthasarathy R; Sen S; Boder ET; Discher DE
Blood; 2006 Mar; 107(6):2548-56. PubMed ID: 16291597
[TBL] [Abstract][Full Text] [Related]
19. Functions and molecular mechanisms of the CD47-SIRPalpha signalling pathway.
Matozaki T; Murata Y; Okazawa H; Ohnishi H
Trends Cell Biol; 2009 Feb; 19(2):72-80. PubMed ID: 19144521
[TBL] [Abstract][Full Text] [Related]
20. An antitumor peptide RS17-targeted CD47, design, synthesis, and antitumor activity.
Wang X; Wang Y; Hu J; Xu H
Cancer Med; 2021 Mar; 10(6):2125-2136. PubMed ID: 33629544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]